These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31049205)

  • 1. Health professionals' and researchers' opinions on conducting clinical deprescribing trials.
    Clough AJ; Hilmer SN; Kouladjian-O'Donnell L; Naismith SL; Gnjidic D
    Pharmacol Res Perspect; 2019 Jun; 7(3):e00476. PubMed ID: 31049205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
    Reeve J; Maden M; Hill R; Turk A; Mahtani K; Wong G; Lasserson D; Krska J; Mangin D; Byng R; Wallace E; Ranson E
    Health Technol Assess; 2022 Jul; 26(32):1-148. PubMed ID: 35894932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey.
    Rozsnyai Z; Jungo KT; Reeve E; Poortvliet RKE; Rodondi N; Gussekloo J; Streit S
    BMC Geriatr; 2020 Oct; 20(1):435. PubMed ID: 33129274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are pharmacists' knowledge and practice the key to promoting deprescribing of potentially inappropriate medication: a missing link between treatment and outcomes.
    El-Dahiyat F; Jairoun AA; Al-Hemyari SS; Shahwan M; Hassan N; Jairoun S; Jaber AAS
    Int J Pharm Pract; 2023 Jun; 31(4):387-395. PubMed ID: 37116892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Reported Barriers and Enablers to Deprescribing Recommendations During a Clinical Trial (Shed-MEDS).
    Kim JL; Lewallen KM; Hollingsworth EK; Shah AS; Simmons SF; Vasilevskis EE
    Gerontologist; 2023 Mar; 63(3):523-533. PubMed ID: 35881109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing.
    Farrell B; Pottie K; Rojas-Fernandez CH; Bjerre LM; Thompson W; Welch V
    PLoS One; 2016; 11(8):e0161248. PubMed ID: 27517450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Reported Barriers and Facilitators to Deprescribing Cardiovascular Medications.
    Goyal P; Requijo T; Siceloff B; Shen MJ; Masterson Creber R; Hilmer SN; Kronish IM; Lachs MS; Safford MM
    Drugs Aging; 2020 Feb; 37(2):125-135. PubMed ID: 31858449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across Europe: a large web-based survey.
    van Poelgeest EP; Seppala LJ; Lee JM; Bahat G; Ilhan B; Lavan AH; Mair A; van Marum RJ; Onder G; Ryg J; Fernandes MA; Garfinkel D; Guðmundsson A; Hartikainen S; Kotsani M; Montero-Errasquín B; Neumann-Podczaska A; Pazan F; Petrovic M; Soulis G; Vankova H; Wehling M; Wieczorowska-Tobis K; van der Velde N;
    Eur Geriatr Med; 2022 Dec; 13(6):1455-1466. PubMed ID: 36319837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers and enablers to deprescribing in long-term care: A qualitative investigation into the opinions of healthcare professionals in Ireland.
    Heinrich CH; McHugh S; McCarthy S; Donovan MD
    PLoS One; 2022; 17(12):e0274552. PubMed ID: 36520798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deprescribing: Future directions for research.
    Thompson W; Reeve E; Moriarty F; Maclure M; Turner J; Steinman MA; Conklin J; Dolovich L; McCarthy L; Farrell B
    Res Social Adm Pharm; 2019 Jun; 15(6):801-805. PubMed ID: 30241876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?
    Djatche L; Lee S; Singer D; Hegarty SE; Lombardi M; Maio V
    J Clin Pharm Ther; 2018 Aug; 43(4):550-555. PubMed ID: 29682764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners.
    Luymes CH; van der Kleij RM; Poortvliet RK; de Ruijter W; Reis R; Numans ME
    Ann Pharmacother; 2016 Jun; 50(6):446-54. PubMed ID: 26939589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare professionals' perspectives of deprescribing in older patients at the end of life in hospice care: a qualitative study using the Theoretical Domains Framework.
    Alwidyan T; McCorry NK; Parsons C
    Int J Pharm Pract; 2023 May; 31(3):305-313. PubMed ID: 36866441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicine, pharmacy and nursing trainees' perceptions of curriculum preparation to deprescribe and interprofessional roles in the deprescribing process.
    Zimmerman KM; Bell CA; Donohoe KL; Salgado TM
    Gerontol Geriatr Educ; 2020; 41(1):63-84. PubMed ID: 31488030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Patient-Preferred Language to Achieve Goal-Aligned Deprescribing in Older Adults.
    Green AR; Aschmann H; Boyd CM; Schoenborn N
    JAMA Netw Open; 2021 Apr; 4(4):e212633. PubMed ID: 33818621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis.
    Langford AV; Gnjidic D; Lin CC; Bero L; Penm J; Blyth FM; Schneider CR
    BMJ Qual Saf; 2021 Feb; 30(2):133-140. PubMed ID: 32220937
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.